Altimmune Stock Technical Analysis
| ALT Stock | USD 5.13 0.34 6.22% |
As of the 6th of February, Altimmune shows the Downside Deviation of 5.7, risk adjusted performance of 0.0754, and Mean Deviation of 4.05. Altimmune technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Altimmune Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Altimmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AltimmuneAltimmune | Build AI portfolio with Altimmune Stock |
Altimmune Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 17.67 | Strong Buy | 9 | Odds |
Most Altimmune analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Altimmune stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Altimmune, talking to its executives and customers, or listening to Altimmune conference calls.
Is there potential for Biotechnology market expansion? Will Altimmune introduce new products? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Altimmune's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Altimmune represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Altimmune's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Altimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Altimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Altimmune.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Altimmune on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Altimmune or generate 0.0% return on investment in Altimmune over 90 days. Altimmune is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, OSR Holdings, Lipocine, and SeaStar Medical. Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver dise... More
Altimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Altimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Altimmune upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.7 | |||
| Information Ratio | 0.0812 | |||
| Maximum Drawdown | 33.75 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 9.8 |
Altimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Altimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Altimmune's standard deviation. In reality, there are many statistical measures that can use Altimmune historical prices to predict the future Altimmune's volatility.| Risk Adjusted Performance | 0.0754 | |||
| Jensen Alpha | 0.495 | |||
| Total Risk Alpha | 0.2438 | |||
| Sortino Ratio | 0.0861 | |||
| Treynor Ratio | 0.603 |
Altimmune February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0754 | |||
| Market Risk Adjusted Performance | 0.613 | |||
| Mean Deviation | 4.05 | |||
| Semi Deviation | 5.19 | |||
| Downside Deviation | 5.7 | |||
| Coefficient Of Variation | 1127.78 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.49 | |||
| Information Ratio | 0.0812 | |||
| Jensen Alpha | 0.495 | |||
| Total Risk Alpha | 0.2438 | |||
| Sortino Ratio | 0.0861 | |||
| Treynor Ratio | 0.603 | |||
| Maximum Drawdown | 33.75 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 9.8 | |||
| Downside Variance | 32.45 | |||
| Semi Variance | 26.92 | |||
| Expected Short fall | (5.13) | |||
| Skewness | (0.48) | |||
| Kurtosis | 4.1 |
Altimmune Backtested Returns
Altimmune appears to be moderately volatile, given 3 months investment horizon. Altimmune secures Sharpe Ratio (or Efficiency) of 0.0812, which signifies that the company had a 0.0812 % return per unit of risk over the last 3 months. By analyzing Altimmune's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Altimmune's Mean Deviation of 4.05, risk adjusted performance of 0.0754, and Downside Deviation of 5.7 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Altimmune holds a performance score of 6. The firm shows a Beta (market volatility) of 0.87, which signifies possible diversification benefits within a given portfolio. Altimmune returns are very sensitive to returns on the market. As the market goes up or down, Altimmune is expected to follow. Please check Altimmune's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Altimmune's price patterns will revert.
Auto-correlation | 0.51 |
Modest predictability
Altimmune has modest predictability. Overlapping area represents the amount of predictability between Altimmune time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Altimmune price movement. The serial correlation of 0.51 indicates that about 51.0% of current Altimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.55 |
Altimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Altimmune Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Altimmune volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Altimmune Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Altimmune on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Altimmune based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Altimmune price pattern first instead of the macroeconomic environment surrounding Altimmune. By analyzing Altimmune's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Altimmune's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Altimmune specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | PTB Ratio | 3.73 | 3.92 | Dividend Yield | 26.32 | 23.4 |
Altimmune February 6, 2026 Technical Indicators
Most technical analysis of Altimmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Altimmune from various momentum indicators to cycle indicators. When you analyze Altimmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0754 | |||
| Market Risk Adjusted Performance | 0.613 | |||
| Mean Deviation | 4.05 | |||
| Semi Deviation | 5.19 | |||
| Downside Deviation | 5.7 | |||
| Coefficient Of Variation | 1127.78 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.49 | |||
| Information Ratio | 0.0812 | |||
| Jensen Alpha | 0.495 | |||
| Total Risk Alpha | 0.2438 | |||
| Sortino Ratio | 0.0861 | |||
| Treynor Ratio | 0.603 | |||
| Maximum Drawdown | 33.75 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 9.8 | |||
| Downside Variance | 32.45 | |||
| Semi Variance | 26.92 | |||
| Expected Short fall | (5.13) | |||
| Skewness | (0.48) | |||
| Kurtosis | 4.1 |
Altimmune February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Altimmune stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.08 | ||
| Daily Balance Of Power | (0.77) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 5.31 | ||
| Day Typical Price | 5.25 | ||
| Price Action Indicator | (0.35) | ||
| Market Facilitation Index | 0.44 |
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.